Prescription RequiredBilypsa contains SAROGLITAZAR 4 mg is a prescription medication used primarily for the treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with type 2 diabetes. It helps manage abnormal cholesterol and triglyceride levels while also improving insulin sensitivity.
| Generic Name | Saroglitazar |
| Manufacturer | Zydus Cadila |
| Packing | 45 Tablets |
| Prescribed For | Anti-Diabetic |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 Tablets | $20 | £15 | A$30 | NZ$33 | ₱1,136 | ₩26,900 | lei 86 | HK$156 | RM83 | ฿636 | د.إ73 |
Saroglitazar prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
Dr. Rajiv Shah is a qualified medical professional with experience in diabetes care and the management of related metabolic conditions. His interests include personalised blood glucose control, medication management, glucose monitoring, nutrition, physical activity and long-term health support.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
